Updated

Rutgers researchers found that popular GLP-1 drugs such as Ozempic and Wegovy are associated with a slightly elevated risk of a rare condition causing sudden, potentially permanent vision loss. While the absolute risk remains very low, the findings are prompting renewed scrutiny given the millions of people now using these medications.